{"id":"W4389516746","doi":"10.1016/j.annonc.2023.09.3104","title":"Lasofoxifene versus fulvestrant for ER+/HER2− metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; McGill University; Jewish General Hospital","funders":"Foundation Medicine; EMD Serono; Eisai; Sanofi; Seagen; Pfizer; Genentech; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Fulvestrant; Medicine; Tolerability; Metastatic breast cancer; Internal medicine; Palbociclib; Oncology; Aromatase inhibitor; Breast cancer; Estrogen receptor; Pharmacology; Cancer; Adverse effect; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001178534,0.001113551,0.001351253,0.0002433519,0.000258472,0.0006830333,0.0004271065,0.001028976,0.003063335],"category_scores_gemma":[0.001088748,0.0003948957,0.001322674,0.000225097,0.0006014314,0.0006082907,0.0002101807,0.001586858,0.0004514689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006029015,"about_ca_system_score_gemma":0.0006818462,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008391272,"about_ca_topic_score_gemma":0.003541992,"domain_scores_codex":[0.9996297,0.0002097226,0.00001872382,0.0000545195,0.0000315276,0.00005567768],"domain_scores_gemma":[0.9995086,0.000155164,0.0001237847,0.00003171302,0.00002958666,0.0001510977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9443243,0.008739135,0.00139394,0.0006338474,0.001058728,0.00007185875,0.00008257887,0.0007606699,0.007723275,0.0001828263,0.001834049,0.03319485],"study_design_scores_gemma":[0.9114963,0.08091861,0.003376689,0.00003313038,0.0006884587,0.0001008824,0.00004012031,0.0005293511,0.0009934149,0.0002524919,0.001552252,0.00001827706],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886534,0.00487627,0.0005296613,0.0009559226,0.0003159225,0.001611473,0.001105611,0.00008289469,0.001868862],"genre_scores_gemma":[0.9871919,0.003428411,0.001130829,0.001337858,0.000339778,0.001531477,0.00110717,0.00002585421,0.003906764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003063335,"threshold_uncertainty_score":0.01024783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1329716577952149,"score_gpt":0.4527071083608898,"score_spread":0.3197354505656749,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}